CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1

This publication has 45 references indexed in Scilit:

• Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients
  New England Journal of Medicine, 1996
• INHIBITION OF GRAFT-VERSUS-HOST DISEASE BY INTERLEUKIN-2 TREATMENT IS ASSOCIATED WITH ALTERED CYTOKINE PRODUCTION BY EXPANDED GRAFT-VERSUS-HOST-REACTIVE CD4+ HELPER CELLS
  Transplantation, 1995
• Cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants as a predictive method for transplantation-related complications
  British Journal of Haematology, 1994
• Lymphokine Production by Human T Cells in Disease States
  Annual Review of Immunology, 1994
• INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT VERSUS HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS1
  Transplantation, 1993
• Differential cytokine expression in acute and chronic murine graft‐versus‐host‐disease
  European Journal of Immunology, 1993
• Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
  The Journal of Experimental Medicine, 1992
• Quantitative analysis of lymphokine expression in vivo and in vitro
  Immunology & Cell Biology, 1992
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
  The Journal of Experimental Medicine, 1987
• CYCLOSPORINE IN ALLOGENEIC BONE MARROW TRANSPLANTATION
  Transplantation, 1986